Guangzhou Huayin Medical Laboratory Center Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2015

Location

Guangzhou Guangdong China

Primary Industry

Healthcare

About

Founded in 2015 and based in Guangzhou, China, Guangzhou Huayin Medical Laboratory Center operates as a medical company that focuses on providing comprehensive medical services. It was recognized as the National High-tech Enterprise. Chunbo Huang, the company's founder, graduated from South China University of Technology and is also the founder of Wondfo Biologics. The company has 18 branch offices in Beijing, Wuhan, Changsha, and other cities. In 2012, it jointly established the Huayin Pathology Diagnostic Center with Southern Medical University. In December 2020, Guangzhou Huayin Medical Laboratory Center raised a pre-IPO funding for CNY 100 million. The company is mainly engaged in medical testing and diagnosis technology services. It has technical platforms such as drug clinical trial centers, public health testing centers, and forensic identification centers. It provides pathological diagnosis, medical testing, genetic testing, health management, public health testing, and other services. The company mainly served clients in clinical testing, pathological diagnosis, public health, forensic identification, and other fields. The company generates revenue by providing testing and diagnosis technology services.

Current Investors

GTJA Investment Group, Bank of China Group Investment, Chongqing Venture Capital

Request a demo to show more

Primary Industry

Healthcare

Sub Industries

Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment, Cardiology

Website

www.huayinlab.com

Verticals

Artificial Intelligence, Big Data, HealthTech

Company Stage

Series C

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.